Zivo Bioscience, Inc. (ZIVO) stock
ZIVOOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$6.80+0.30 (+4.62%)
Close on Oct 19, 2026Market cap $25.96MP/E –Yield –
Zivo Bioscience enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Zivo Bioscience's enterprise value was $26.01M on Oct 19, 2026, against $53.43M a year earlier. Over the last 5 years it ranged from -$260.91K to $214.95M, with a median of $60.50M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $26.01M | -21.9% |
| 2025 | Dec 31, 2025 | $33.30M | -55.5% |
| 2024 | Dec 31, 2024 | $74.88M | +11837.2% |
| 2023 | Dec 29, 2023 | $627.32K | -99.5% |
| 2022 | Dec 30, 2022 | $138.17M | -8.7% |
| 2021 | Dec 31, 2021 | $151.36M | -58.7% |
| 2020 | Dec 31, 2020 | $366.18M | +0.4% |
| 2019 | Dec 31, 2019 | $364.89M | +178.1% |
| 2018 | Dec 31, 2018 | $131.20M | +75.3% |
| 2017 | Dec 29, 2017 | $74.86M | -8.0% |
| 2016 | Dec 30, 2016 | $81.38M | +21.0% |
| 2015 | Dec 31, 2015 | $67.27M | +9.2% |
| 2014 | Dec 31, 2014 | $61.61M | -76.8% |
| 2013 | Dec 31, 2013 | $265.58M | +125.9% |
| 2012 | Dec 31, 2012 | $117.58M | -19.8% |
| 2011 | Dec 30, 2011 | $146.58M | – |
See a number that looks wrong?